These results suggest that dyslipidemia may be partly responsible for vascular and autonomic dysfunctions and that protective effects of PARP-1 inhibition on these abnormalities may be mediated partly through its effects on lipid profile (Figure 4). The gene discussed is PARP1; the disease is Abnormal autonomic nervous system physiology.